Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10395233 | 0.91 | TSHR (0.40) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10394481 | 0.91 | TSHR (0.40) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL15981078 | 0.89 | TSHR (0.39) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10395235 | 0.89 | CA12 (0.42) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10395211 | 0.89 | CA12 (0.42) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL8912967 | 0.85 | TSHR (0.40) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10394487 | 0.85 | TSHR (0.40) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10395210 | 0.85 | CA12 (0.36) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10395700 | 0.85 | CYP3A4 (0.50) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL10395314 | 0.85 | CYP3A4 (0.50) | TSHRCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109910406-A | Non-woven fabric for automotive interior and preparation method thereof | 朱建余 | 2019-06-21 | — | — | CN | claimed |
| US-4820698-A | TETRAALKYL ETHENYLIDENEBISPHOSPHONATES | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-11 | — | — | US | claimed |
| EP-0221611-A2 | Antimicrobial agents and process for their manufacture | THE PROCTER & GAMBLE COMPANY (US) | 1987-05-13 | — | — | EP | claimed |
| JP-9202794-A | — | — | None | — | — | JP | disclosed |
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | AJINOMOTO CO., INC. (JP) | 2026-04-07 | — | — | US | disclosed |
| US-20220267264-A1 | METHOD FOR PRODUCING DERIVATIVE OF ORGANIC SUBSTANCE AND METHOD FOR ANALYZING SAMPLE CONTAINING ORGANIC SUBSTANCE | AJINOMOTO CO., INC. (JP) | 2022-08-25 | — | — | US | disclosed |
| US-20220002576-A1 | GAS-ACTIVATED CYANOACRYLATES FOR 3-D PRINTING | HENKEL AG & CO KGAA (DE) | 2022-01-06 | — | — | US | disclosed |
| US-RE48510-E1 | Phosphorus functional antimicrobial coatings for metal surfaces | NANO SAFE COATINGS INCORPORATED (US) | 2021-04-13 | — | — | US | disclosed |
| WO-2020187548-A1 | GAS-ACTIVATED CYANOACRYLATES FOR 3D-PRINTING | HENKEL AG & CO. KGAA (DE) | 2020-09-24 | — | — | WO | disclosed |
| EP-3708370-A1 | 3D-PRINTING METHOD USING GAS-ACTIVATED CYANOACRYLATES | Henkel AG & Co. KGaA (DE) | 2020-09-16 | — | — | EP | disclosed |
| EP-3235822-B1 | NOVEL BISPHOSPHONIC ACID DERIVATIVE AND APPLICATION FOR SAME | UNIV NAGASAKI (JP) | 2020-01-29 | — | — | EP | disclosed |
| EP-0321233-A1 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-06-21 | — | — | EP | disclosed |
| US-4820698-A | TETRAALKYL ETHENYLIDENEBISPHOSPHONATES | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0230068-A2 | Use of a geminal diphosphonic acid compound to prepare a medicament | Norwich Eaton Pharmaceuticals, Inc. (US) | 1987-07-29 | — | — | EP | disclosed |
| EP-0221611-A2 | Antimicrobial agents and process for their manufacture | THE PROCTER & GAMBLE COMPANY (US) | 1987-05-13 | — | — | EP | disclosed |
| EP-0186405-A2 | Pharmaceutical compositions containing geminal diphosphonates | THE PROCTER & GAMBLE COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
| EP-0068584-B1 | BORON CONTAINING POLYPHOSPHONATES FOR THE TREATMENT OF CALCIFIC TUMORS | THE PROCTER & GAMBLE COMPANY (US) | 1985-09-25 | — | — | EP | disclosed |
| US-4399817-A | Boron containing polyphosphonates for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
| EP-0068584-A1 | Boron containing polyphosphonates for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |
| US-4246103-A | INHIBIT PRECIPITATION OF HARD WATER IONS ESPECIALLY FOR INDUSTRIAL WATER AND SLUDGE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | SULT1E1, CNR2, SRMS | TSHR 2375/4885CA12 1482/4885CA1 1758/4885 |
| US-20220267264-A1 | METHOD FOR PRODUCING DERIVATIVE OF ORGANIC SUBSTANCE AND METHOD FOR ANALYZING SAMPLE CONTAINING ORGANIC SUBSTANCE | SORD, STS, SULT2A1 | TSHR 2969/4885CA12 3759/4885CA1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.